Both in Pharmaceuticals
Bausch Health Companies vs Enliven Therapeutics
Over the past year BHC returned +19.5% and ELVN returned +124.2%; their daily moves had a correlation of 0.02.
BHC +19.5% ELVN +124.2%Growth of $1, one year, split-adjusted
| Metric | BHC | ELVN |
|---|---|---|
| Price | $8.14 | $44.83 |
| Market cap | $3.05B | $3.28B |
| Today | +1.50% | +0.45% |
| 1 month | +38.2% | −1.4% |
| 6 months | +44.3% | +7.8% |
| Year to date | +17.1% | +191.1% |
| 1 year | +16.0% | +91.4% |
| Revenue growth (YoY) | +9.7% | — |
| Gross margin | 75.0% | — |
| Net margin | 14.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | -$18.15B | $895.2M |
| Dividend yield | — | — |
| Volatility (60d) | 67.8% | 40.1% |
| Short % of float | 3.1% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).